Potential Sciences, a UK-based startup, is leveraging artificial intelligence to enhance drug discovery by creating extensive chemical datasets through simulations. This approach aims to identify effective drug candidates more rapidly, potentially reducing costs and time associated with traditional lab experiments.
The startup has received backing from the UK government and aims to develop tailored treatments for diseases, particularly rare conditions. However, it faces significant competition in the crowded AI drug discovery market and must navigate challenges related to safety testing and potential misuse of its technology.